| Literature DB >> 25803794 |
Maria Fernanda Falcone-Dias1, Daniela Centrón2, Fernando Pavan3, Adriana Candido da Silva Moura3, Felipe Gomes Naveca4, Victor Costa de Souza4, Adalberto Farache Filho3, Clarice Queico Fujimura Leite3.
Abstract
Several differences concerning bacterial species, opportunistic pathogens, elements of the resistome as well as variations concerning the CFU/mL counts were identified in some of the five most marketed bottled mineral water from Araraquara city, São Paulo, Brazil. Two out of five brands tested were confirmed as potential source of opportunistic pathogens, including Mycobacterium gordonae, Ralstonia picketti and Burkholderia cepacia complex (Bcc). A total of one hundred and six isolates were recovered from four of these bottled mineral water brands. Betaproteobacteria was predominant followed by Alphaproteobacteria, Gammaproteobacteria and Firmicutes. Ninety percent of the bacteria isolated demonstrated resistance to seventeen of the nineteen antimicrobials tested. These antimicrobials included eight different classes, including 3rd and 4th generation cephalosporins, carbapenems and fluoroquinolones. Multidrug resistant bacteria were detected for fifty-nine percent of isolates in three water brands at counts up to 103 CFU/ml. Of major concern, the two bottled mineral water harboring opportunistic pathogens were also source of elements of the resistome that could be directly transferred to humans. All these differences found among brands highlight the need for continuous bacteriological surveillance of bottled mineral water.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25803794 PMCID: PMC4372423 DOI: 10.1371/journal.pone.0121284
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Colony forming units (CFU) of culturable bacteria per 100 ml of bottled mineral water, as recovered on R2A and PIA and in the same culture media supplemented with amoxicillin (AML, 32 mg/L) or ciprofloxacin (CIP, 4 mg/L) at 48 h of incubation.
| Brand | Mean ± SD | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R2A | R2A-AML | R2A-CIP | PIA | PIA-AML | PIA-CIP | |||||||
|
| 4.70 ± 0.09 | a, 1 | 1.38 ± 0.05 | b, 1 | 1.47 ± 0.06 | b, 1 | 4.29 ± 0.10 | a, 1 | 0.68 ± 0.35 | b, 1 | 0.67 ± 0.19 | b, 1 |
|
| 5.34 ± 0.03 | a, 2 | 4.71 ± 0.05 | b, 2 | 1.85 ± 0.00 | c, 2 | 4.42 ± 0.15 | a, 1 | 3.11 ± 0.11 | b, 2 | 2.19 ± 0.34 | c, 2 |
|
| < 0 | 3 | < 0 | 3 | < 0 | 3 | < 0 | 2 | < 0 | 3 | < 0 | 3 |
|
| < 0 | 3 | < 0 | 3 | < 0 | 3 | < 0 | 2 | < 0 | 3 | < 0 | 3 |
|
| 6.49 ± 0.14 | a, 4 | 4.72 ± 0.05 | b, 2 | < 0 | c, 3 | 5.79 ± 0.02 | a, 3 | 3.05 ± 0.10 | b, 2 | < 0 | c, 3 |
Letters indicate significant (P<0.05) differences between culture medium with antibiotic and the same culture medium without antibiotic for each brand;
Numbers indicate significant differences (P<0.05) between the brands for each culture medium.
*SD, standard deviation; values are the means of three determinations;
Fig 1A dendrogram representing the diversity of species isolated from mineral waters.
The isolate designation are of the IMAi type, in which I is the water brand (A, B, D or E); M, the culture medium on which it was isolated (R, for R2A or P, for PIA); A, indicates the supplementation with antibiotic (O, none, A, amoxicillin, and C, ciprofloxacin); and i indicates the number of isolates that were used for 16S rRNA gene sequence analysis.
Antibiotic resistance patterns observed for each species, corresponding to a total of 106 bacterial isolates from mineral waters.
| Brand | Species | Tax. | N° isolates | Antibiotics | MDR | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Beta-lactams | Aminoglycosides | Quinolones | Polymyxin | Sulfonamides | Tetracycline | (n° ofresistant classes/ | |||||||||||||||||
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | n°of classes tested) | ||||
|
|
| GP | 16 | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S |
|
| S | - |
|
| GP | 1 | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S |
|
| S | - | |
|
| F | 9 | S | S | S |
| S | S | S |
| S | S |
|
| S | S | S | S |
| S | S | MDR (4/8) | |
|
| A | 10 | S | S | S |
| S | S | S |
| S | S |
|
|
| S | S | S |
| S | S | MDR (4/8) | |
|
|
| BP | 17 |
|
| S |
| S |
|
| S |
|
| I |
| S |
| S | S |
|
| S | MDR (6/8) |
|
| F | 1 | S | S | S | S | S | S | S | S | S |
| S | S | S | S | S | S | S | S | S | - | |
|
| BP | 3 | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | - | |
|
| BP | 5 |
|
| S | S | S | S |
|
|
|
| I |
|
|
|
| S |
|
|
| MDR (8/8) | |
|
| B | 5 |
| S |
|
| S | S |
|
|
|
|
|
|
|
| S | S |
|
| S | MDR (6/8) | |
|
| BP | 5 |
|
| S | S | S | S |
|
| S |
| S |
| I |
|
| S |
|
|
| MDR (8/8) | |
|
|
| AP | 12 | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S |
| S | S | - |
|
| AP | 11 | S | S | S | S | S | S | S | S | S |
|
| S | S | S | S | S |
| S | S | MDR (3/8) | |
|
| BP | 3 | S | S | S | S | S | S | S | S | S | S |
| S | S |
| S | S | S | S | S | - | |
It was not possible to perform a disc diffusion assay onthe Bradyrhizobiumelkanii strain that was recovered from brand D because the bacteria only showed growth after 7 days.
R, resistant; S, sensible; I, intermediate
aTaxonomical identification: AP, Alphaproteobacteria; BP, Betaproteobacteria; GP, Gammaproteobacteria; B, Bacteroidetes; A, Actinobacteria; and F, Firmicutes.
bMDR (multiple antibiotic resistant), represents species resistant to 3 or more distinct antibiotic classes.
cAntibiotics: 1, ticarcillin (75 μg); 2, ticarcillin-clavulanic acid (75/10 μg); 3, cefepime (30 μg); 4, ceftazidime (10 μg); 5, imipenem (10 μg); 6, meropenem (10 μg); 7, gentamicin (10 μg); 8, tobramycin (10 μg); 9, amikacin (30 μg); 10, streptomycin (10 μg); 11, nalidixic acid (30 μg); 12 ciprofloxacin (10 μg); 13 levofloxacin (5 μg); 14, colistin (10 μg); 15, sulfamethoxazole (25 μg); 16, sulfamethoxazole/trimethoprim (1.25 μg trimethoprim and 23.75 μg sulfamethoxazole); 17, fosfomycin (50 μg); 18, rifampicin (5 μg); and 19, tetracycline (30 μg).
Fig 2The resistome of three mineral water brands.